Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Extending Hope: Broadening Access to CAR T-Cell Therapies Ayesha A. Pandit, M.D., M.S., MBA Vice President Oncology and Hematology Medical Affairs CAR T-cell therapies have transformed the therapeutic landscape for hematologic malignancies, offering substantial benefit to patients with few altern... 2 days ago | 40 mins Extending Hope: Broadening Access to CAR T-Cell Therapies Ayesha A. Pandit, M.D., M.S., MBA Vice President Oncology and Hematology Medical Affairs CAR T-cell therapies have transformed the therapeutic landscape for hematologic malignancies, offering substantial benefit to patients with few altern... 1 month ago | 40 mins 固形がんにおけるDNAミスマッチ修復(MMR) 機能異常とその臨床的意義 〜IHC検査とがん免疫療法の臨床事例を踏まえて〜 Dr. Takeshi Kuwata and Dr. Akihito Kawazoe, both from National Cancer Center Hospital East, Chiba, Japan (Note: This webinar will be presented in Japanese.) In this webinar, our speakers will discuss mechanisms and clinical evaluation of DNA mismatch repa... 7 months ago | 62 mins Immunotherapies are the scientific answer to cancer, how important is marketing? Michael Gaschler, Cerner Enviza; Jeanette Hodgson, Cerner Enviza; Mark Sales, Cerner Enviza; Mini Pinto, Merck & Co., Inc. Once widely acknowledged as so special that only scientists and clinical specialists need apply, oncology has become exponentially more clinically tar... 1 year ago | 64 mins The Pathologist in the Era of Immunotherapy Dr. Ken Bloom The job of the pathologist is crucial in the era of precision medicine and immunotherapy. Pathologists need not only to correctly diagnose and classi... 3 years ago | 61 mins CAR-T and other immunotherapies Iain Armstrong (Partner, HGF), Peter Scott (Editor-in-Chief, LSIPR) Immunotherapies, such as CAR-T cells, are a hugely promising therapeutic area, both in terms of clinical benefits and potential market size. While t... 4 years ago | 62 mins Mismatch Repair Immunohistochemistry in Clinical Oncology Dr. Takeshi Kuwata and Dr. Akihito Kawazoe, both from National Cancer Center Hospital East, Chiba, Japan This webinar will discuss mechanisms and clinical evaluation of DNA mismatch repair (MMR) status in solid tumor oncology. Speakers will present case s... 1 year ago | 60 mins Module 2: Ventana PD-L1 (SP263) Assay NSCLC Evaluation Education Dr. Dorothy Hayden, Pathologist at Roche Tissue Diagnostics This series of videos is provided as a resource for individuals in countries where VENTANA PD-L1 (SP263) Assay is approved for use for non-small cell ... 3 years ago | 18 mins Development of a 3D organoid autologous TIL co-culture platform for IO studies Garima Kaushik, PhD - Champions Oncology Champions Oncology was excited to participate in the Society for Immunotherapy of Cancer’s (SITC) Virtual Meeting in November. Due to the limited avai... 2 years ago | 23 mins Lung Cancer Diagnostics: Evolving Practice and Future Directions Professor Keith Kerr Personalized medicine for non-small-cell lung cancer (NSCLC) continues to evolve rapidly, building on a solid diagnostic foundation based on H&E and i... 3 years ago | 61 mins Load more
